These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21766430)

  • 21. The role of teratology information services in screening for teratogenic exposures: challenges and opportunities.
    Chambers C
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):195-200. PubMed ID: 21748849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Teratogens and teratogenesis: general principles of clinical teratology.
    Frias JL; Thomas IT
    Ann Clin Lab Sci; 1988; 18(2):174-9. PubMed ID: 3289471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of the potential teratogenic effect of large doses of promethazine used for a suicide attempt by 32 pregnant women.
    Petik D; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):87-96. PubMed ID: 18818185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The possible teratogenic effect of levamisole treatment during pregnancy].
    Kazy Z; Puchó E; Czeizel E
    Orv Hetil; 2005 Dec; 146(49):2499-500. PubMed ID: 16398315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring for teratogenic signals: pregnancy registries and surveillance methods.
    Howard TB; Tassinari MS; Feibus KB; Mathis LL
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):209-14. PubMed ID: 21766431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human teratogens update 2011: can we ensure safety during pregnancy?
    Rasmussen SA
    Birth Defects Res A Clin Mol Teratol; 2012 Mar; 94(3):123-8. PubMed ID: 22328359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population-based case-control teratogenic study of hydroxyprogesterone treatment during pregnancy.
    Dudás I; Gidai J; Czeizel AE
    Congenit Anom (Kyoto); 2006 Dec; 46(4):194-8. PubMed ID: 17096820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Principles of human teratology: drug, chemical, and infectious exposure.
    Wilson RD; ;
    J Obstet Gynaecol Can; 2007 Nov; 29(11):911-917. PubMed ID: 17977495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving knowledge of the teratogenicity of medications in human pregnancy.
    Adam MP; Polifka JE; Friedman JM
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):175-82. PubMed ID: 21766440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of associations between birth defects and suspected human teratogens.
    Khoury MJ; James LM; Lynberg MC
    Am J Med Genet; 1991 Sep; 40(4):500-5. PubMed ID: 1746618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic basis of susceptibility to teratogen induced birth defects.
    Wlodarczyk BJ; Palacios AM; Chapa CJ; Zhu H; George TM; Finnell RH
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):215-26. PubMed ID: 21766441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of teratogenic and fetotoxic effects of large doses of meprobamate used for a suicide attempt by 42 pregnant women.
    Timmermann G; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):97-107. PubMed ID: 18818186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peyote use during pregnancy.
    Gilmore HT
    S D J Med; 2001 Jan; 54(1):27-9. PubMed ID: 11211421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Teratology and epidemiology in the study of environmental teratogens].
    Cayré R; Sánchez-Gómez C; Moreno-Rodríguez RA; de la Cruz MV
    Bol Med Hosp Infant Mex; 1992 Jul; 49(7):397-403. PubMed ID: 1418645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lasting effects of chemical agents on the developing nervous system: functional teratology].
    Swaab DF
    Ned Tijdschr Geneeskd; 1989 Feb; 133(5):246-9. PubMed ID: 2467214
    [No Abstract]   [Full Text] [Related]  

  • 37. Reproductive toxicology and teratology of abused toluene.
    Hannigan JH; Bowen SE
    Syst Biol Reprod Med; 2010 Apr; 56(2):184-200. PubMed ID: 20377315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium periconceptional exposure: pregnancy and neonatal outcome.
    De Santis M; Straface G; Cavaliere AF; Carducci B; Caruso A
    Acta Obstet Gynecol Scand; 2007; 86(1):99-101. PubMed ID: 17230297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Identification of teratogenic risk factors by a case-control approach].
    Calzolari E
    Pathologica; 1986; 78(1058):803-7. PubMed ID: 3696789
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse environmental exposures in pregnancy: teratology in adolescent medicine practice.
    Seaver LH
    Adolesc Med; 2002 Jun; 13(2):269-91, vi. PubMed ID: 11986036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.